Pfizer shares rise 1.68% and snap three-day losing streak
Updated
Updated · MarketWatch · Apr 30
Pfizer shares rise 1.68% and snap three-day losing streak
9 articles · Updated · MarketWatch · Apr 30
The stock closed at $26.70 on Thursday as the S&P 500 gained 1.02% to 7,209.01 and the Dow rose 1.62% to 49,652.14.
Pfizer outperformed Johnson & Johnson and Abbott Laboratories, though Eli Lilly surged 9.80%, and trading volume reached 38.4 million shares, above its 50-day average of 37.7 million.
Despite the rebound, Pfizer remains 7.11% below its 52-week high of $28.75 reached on 2 April.
Is Pfizer's high dividend a sign of confidence or a risky promise amid its transformation?
As rivals dominate the weight-loss market, can Pfizer's new drugs truly compete for a share?
Can Pfizer's new drug pipeline and AI strategy outrun its looming multi-billion dollar patent cliff?